510(k) Report

FDA applicant

Cardiovascular Innovations

Dallas, TX1 decision1998–19982 recalls

FDA records 1 decision for Cardiovascular Innovations (Dallas, TX) in 1998: 1 510(k) clearance. All are in product code DXT (Injector And Syringe, Angiographic). Its devices cite 2 predicates, 0 of them its own earlier devices. 2 recalls are linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, cardiovascular panel, where it files most

How often FDA has decided Cardiovascular Innovations’s devices, and how often a recall has named them.

FDA decisions per year

No FDA decision for Cardiovascular Innovations since 2007.

Recalls per year

1in 2021

2007: 12021: 1
2007high 1 (2007) · low 0 (2008)2026

Class I Class II/III not classified

FIG. 1 — Cardiovascular Innovations by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Cardiovascular Innovations’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Cardiovascular”

FDA records each applicant name separately; these may or may not be the same firm.